Ian Ardill

Chief Financial Officer

Ian is an experienced finance executive with 20 years’ experience in pharmaceutical and medical technology companies.  He was CFO of Diurnal Group, where he managed the company’s IPO and admission to the AIM Market; Lombard Medical, where he was responsible for the company’s final AIM fundraising followed by its AIM delisting and IPO on NASDAQ; and Biocompatibles International, where he led the group financially to profitability and subsequent sale to BTG.  Ian’s experience includes IPOs, fundraising, acquisitions and disposals in private and public Life Sciences companies along with supporting early stage companies with their financial and accounting needs.  He is a qualified Chartered Accountant.